Last reviewed · How we verify
NCT03964285: PRFM-3
Repetitive Thinking in Fibromyalgia
NA trial testing rumination induction in Rumination in 47 participants. Completed in 25 February 2020.
25 February 2020
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire, Amiens |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 47 |
| Start date | 26 February 2019 |
| Primary completion | 25 February 2020 |
| Estimated completion | 25 February 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- rumination induction
- distraction induction
Conditions studied
- Rumination — all drugs for Rumination →
- Fibromyalgia — all drugs for Fibromyalgia →
- Chronic Pain — all drugs for Chronic Pain →
- Repetitive Negative Thinking — all drugs for Repetitive Negative Thinking →
Sponsor
Centre Hospitalier Universitaire, Amiens
Who can join
18 and older, any sex, with Rumination or Fibromyalgia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Some fibromyalgia patients may use inappropriate emotional regulation strategies to respond to pain. Rumination could be one of this inefficient regulation strategies. The investigators believe that the use of rumination strategies to respond to the discomfort of daily physical activity would maintain and aggravate a negative emotional state after the effort. Distraction would be a more effective strategy to cope with pain. From this data, the investigators want to explore the causal link between rumination and negative affectivity after physical activity in fibromyalgia using an experimental design.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03964285
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rumination
Currently open trials in the same condition.
- NCT07478393 — Readiness and Progress in Emotion Regulation Therapy · NA · recruiting
- NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
- NCT06937476 — Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole · NA · active not recruiting
- NCT06828276 — Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants · NA · recruiting
- NCT05617495 — Mindfulness-Based fMRI Neurofeedback for Depression · NA · recruiting
Other Centre Hospitalier Universitaire, Amiens trials
Trials by the same sponsor.
- NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
- NCT07071662 — Induction of Labor in Breech Presentation · completed
- NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
- NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
- NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03964285 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
- Last refreshed: 19 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03964285.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing